Moderna Free Cash Flow 2017-2025 | MRNA

Moderna free cash flow for the twelve months ending March 31, 2025 was , a year-over-year.

  • Moderna annual free cash flow for 2024 was $-4.055B, a 6.01% increase from 2023.
  • Moderna annual free cash flow for 2023 was $-3.825B, a 183.5% decline from 2022.
  • Moderna annual free cash flow for 2022 was $4.581B, a 65.65% decline from 2021.

Moderna Free Cash Flow 2017-2025 | MRNA

  • Moderna annual free cash flow for 2024 was $-4.055B, a 6.01% increase from 2023.
  • Moderna annual free cash flow for 2023 was $-3.825B, a 183.5% decline from 2022.
  • Moderna annual free cash flow for 2022 was $4.581B, a 65.65% decline from 2021.